Becton Dickinson & Co.

BDX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $12.09B $12.48B $10.28B $8.45B $8.05B $7.71B $7.58B $7.12B
BD Medical $8.11B $8.65B
BD Life Sciences $3.99B $3.83B
BD Interventional
Corporate and Other
Cost of Revenue $6.13B $6.49B $5.59B $4.15B $3.88B $3.76B $3.63B $3.43B
Gross Profit $5.94B $5.99B $4.70B $4.30B $4.17B $3.95B $3.96B $3.70B
Gross Margin 49.1% 48.0% 45.7% 50.9% 51.8% 51.3% 52.2% 51.9%
Operating Expenses
Research & Development $770.0M $828.0M $632.0M $550.0M $494.0M $472.0M $470.0M $422.8M
SG&A Expense $2.91B $3.01B $2.56B $2.15B $2.42B $1.92B $1.82B $1.69B
Operating Income $1.52B $1.43B $1.07B $1.61B $1.25B $1.56B $1.67B $1.58B
Operating Margin 12.6% 11.5% 10.4% 19.0% 15.6% 20.2% 22.0% 22.2%
Interest Expense $521.0M $388.0M $371.0M $135.0M $138.0M $135.0M $84.0M $51.3M
Pretax Income $976.0M $1.07B $739.0M $1.52B $1.17B $1.47B $1.62B $1.57B
Income Tax Expense $-124.0M $97.0M $44.0M $337.0M $236.0M $363.0M $417.0M $451.9M
Net Income $1.10B $976.0M $695.0M $1.19B $1.29B $1.17B $1.27B $1.32B
Net Margin 9.1% 7.8% 6.8% 14.0% 16.1% 15.2% 16.8% 18.5%
EPS (Basic) $4.70 $4.59 $3.43 $6.13 $6.63 $5.69 $5.75 $5.62
EPS (Diluted) $4.60 $4.49 $3.35 $5.99 $6.49 $5.59 $5.62 $5.49
Shares Outstanding (Basic) 218.9M 212.7M 202.5M 193.3M 195.2M 205.5M 221.2M 234.3M
Shares Outstanding (Diluted) 223.6M 217.5M 207.5M 197.7M 199.2M 209.2M 226.3M 240.1M
Dividends Per Share $2.92 $2.64 $2.40 $2.18 $1.98 $1.48
← Newer Page 2 of 3 Older →